Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia
2006

Combining Chloroquine and Sulfadoxine/Pyrimethamine for Malaria Treatment

Sample size: 117 publication 10 minutes Evidence: high

Author Information

Author(s): Lederman Edith R, Maguire Jason D, Sumawinata Iwa W, Chand Krisin, Elyazar Iqbal, Estiana Lusi, Sismadi Priyanto, Bangs Michael J, Baird J Kevin

Primary Institution: U.S. Naval Medical Research Unit No.2, Jakarta, Indonesia

Hypothesis

Combining chloroquine with sulfadoxine/pyrimethamine may provide a more effective treatment for uncomplicated falciparum malaria in Central Java, Indonesia.

Conclusion

The combination of chloroquine and sulfadoxine/pyrimethamine was found to be highly effective for treating uncomplicated falciparum malaria.

Supporting Evidence

  • Chloroquine combined with sulfadoxine-pyrimethamine showed a 94% efficacy compared to 58% for chloroquine alone.
  • The addition of primaquine improved gametocyte clearance rates significantly.
  • The study included 117 subjects with uncomplicated falciparum malaria.

Takeaway

This study shows that using two malaria medicines together works better than using just one. It's like having two superheroes fighting the bad guys instead of just one!

Methodology

The study compared the effectiveness of chloroquine alone versus chloroquine combined with sulfadoxine/pyrimethamine and/or primaquine in treating uncomplicated falciparum malaria.

Potential Biases

Potential biases may arise from the study's design and participant selection process.

Limitations

The study was conducted in a specific region, and results may not be generalizable to other areas with different malaria resistance patterns.

Participant Demographics

Participants were aged 16 to 65 years, with a male to female ratio of approximately 1.2:1.

Statistical Information

P-Value

0.00003

Confidence Interval

95% CI 2.74 – 18.57

Statistical Significance

p < 0.001

Digital Object Identifier (DOI)

10.1186/1475-2875-5-108

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication